Stage IVA Colorectal Cancer Withdrawn Phase 1 Trials for Leucovorin (DB00650)

IndicationStatusPhase
DBCOND0068496 (Stage IVA Colorectal Cancer)Withdrawn1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02573220Irinotecan Hydrochloride With FOLFIRI and Cetuximab as First-Line Therapy in Treating Patients With RAS Wild-Type Colorectal CancerTreatment